Abstract
The pharmacokinetics of antimigraine drugs zolmitriptan and sumatriptan varied considerably with a fourfold to 10-fold variation in plasma levels. In addition, the pharmacodynamics of triptans as investigated in vitro also varied considerably. In theory, there should probably be a 10-fold variation in doses available, but in clinical practice a fourfold difference in doses will probably cover the needs of most patients.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Cephalalgia : an international journal of headache |
| Vol/bind | 27 |
| Udgave nummer | 10 |
| Sider (fra-til) | 1091-3 |
| Antal sider | 3 |
| ISSN | 0333-1024 |
| DOI | |
| Status | Udgivet - okt. 2007 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Pharmacokinetic and pharmacodynamic variability as possible causes for different drug responses in migraine. A comment'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS